Creative Hackers Find A Niche In Japan

TOKYO—Takashi Chikayama is a true hacker—a person who spends long hours working to crack difficult software codes, not because he’s paid overtime, but because he loves programming. Unlike most members of his scientific cadre however, he doesn’t work in a basement university lab in Cambridge, Mass., or a plush office in Silicon Valley. Chikayama’s home is Tokyo—and he is Japan’s newest and quite possibly most potent weapon in the international battle

Written byColin Johnson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

TOKYO—Takashi Chikayama is a true hacker—a person who spends long hours working to crack difficult software codes, not because he’s paid overtime, but because he loves programming. Unlike most members of his scientific cadre however, he doesn’t work in a basement university lab in Cambridge, Mass., or a plush office in Silicon Valley. Chikayama’s home is Tokyo—and he is Japan’s newest and quite possibly most potent weapon in the international battle to control the lucrative high technology market for computer software.

Japan’s rising supremacy in the realm of hardware is not news. Today, companies like NEC and Hitachi, rather than Motorola and Texas Instruments, have the most sophisticated microchip fabrication facilities. Fujitsu has produced the fastest supercomputer. And this past December, Japan’s Institute for New Generation Computer Technology (ICOT) announced the latest coup: parity with the West in the area of parallel processors, the machines needed to run the artificial ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies